Post on 22-Apr-2021
HYPERTENSIVE
Orbit’sHYPERTENSIVE
Portfolio
Hypertension (HTN or HT), also known as high blood pressure (HBP), is a long-term medical condition in which the blood pressure in the arteries is persistently elevated.High blood pressure usually does not cause symptoms. Long-term high blood pressure, however, is a major risk factor for coronary artery disease, stroke, heart failure, atrial fibrillation, peripheral vascular disease, vision loss, chronic kidney disease, and dementia.
Below listed the Orbit’s Portfolio
NAME
Ramipril Capsules BP 5 mg
Ramipril Capsules BP 2.5 mg
Ramipril & Hydrochlorothiazide Capsules (2.5 mg + 12.5 mg)
Nifedipine Sustained release tablets 10 mg
Nifedipine Sustained release tablets 20 mg
Enalapril Maleate Tablets USP 10 mg
Enalapril Maleate Tablets USP 5 mg
Amlodipine Besilate Tablets 5 mg
Amlodipine Besilate Tablets 10 mg
Amlodipine and Atenolol Tablets (5 mg + 50 mg)
Nimodipine tablets BP 30 mg
Atenolol Tablet BP 50 mg
Atenolol Tablet BP 100 mg
Propranolol Tablets BP 40 mg
Losartan Potassium Tablets USP 25 mg
Losartan Potassium Tablets USP 50 mg
Losartan Potassium Tablets USP 100 mg
Losartan potassium & Hydrochlorothiazide Tablets USP 50mg + 12.5mg
Lisinopril Tablets BP 5 mg
Lisinopril Tablets BP 10 mg
Atorvastatin Tablets 10 mg
Atorvastatin Tablets 20 mg
Atorvastatin Tablets 40 mg
Isoxsuprine Hydrochloride Sustained Release Tablets 40 mg
HYPERTENSIVE
Captopril Tablets BP 25 mg
Captopril Tablets BP 50 mg
Telmisartan Tablets USP 20 mg
Telmisartan Tablets USP 40 mg
Isosorbide Dinitrate Tablets U.S.P. 20 mg
Amlodipine 5/10 mg
Amlodipine 5mg + Atenolol 50mg
Bisoprolol fumrate 2.5mg + Amlodipine 2.5mg
Cilnidipine 5/10mg/20 MG
Cilnidipine 5mg + Chlorthalidone 12.5mg
Clopidogrel Bisulphate 75mg
Clopidogrel Bisulphate 75mg + Aspirine 75mg
Hydrochlorthiazide 12.5/25mg
Irbesartan 150mg + Chlorthalidon 12.5mg
Losartan Pottasium 25/50/100mg
Losartan Pottasium 25/50mg + Ramipril 2.5mg
Metiprolol Succinate 25mg + Telmisartan 40mg
Metoprolol Succinate (Extended Realease) 25/50/100mg
Metoprolol Succinate 25mg + Clopidogrel 75mg
Nebivilol 5mg + S-Amlodipine 2.5mg
Nebivolol Hcl 5/10mg
Nicorandil 5/10mg
Olmesaratan Medoximil 20mg + Amlodipine Basilate 5mg
Olmesartan Medoxomil 20/40mg + chlorthalidone 12.5mg
Olmesartan Medoxomil 20/40mg + Hydrochlorthiazide 12.5mg
Olmesartan 20mg + Amlodipine 5mg + Hydrochlorthiazide 12.5 mg
Olmesartan 40mg + Amlodipine 5mg
Propanolol Hcl 10mg
Ramipril 2.5/5/10mg
Telmisartan 20/40/80 mg
Telmisartan40mg + Amlodipine 5mg
Telmisartan 40mg + Chlorthalidone 12.5mg
Telmisartan 40mg + Cilnidipine 10mg
ABOUT ORBIT
Orbit LifeSciences - Pioneer In Delivering Health Outcomes
The information in this document is the property of Orbit or its licensors and is protected by copyright and other intellectual property laws. The information in this document is confidential and may be legally privileged or exempt from disclosure under applicable law and shall not attach any liability on the originator. It is intended solely for the addressee. This document shall and will neither be copied, distributed nor have the contents disseminated to anyone else aside from the addressee, without the prior approval of Alhev Access to this document by anyone else is unauthorized. If you are not the intended recipient, or a person responsible for delivery of this document to an intended recipient, any disclosure, copying, distribution or any action taken or omitted to be taken in reliance on it, is prohibited and may be unlawful. Also, you may not copy, print, store, deliver, disseminate or distribute this document to anyone. If you have received this document in error or in such a case, as described herein, please destroy this document and any copies immediately and notify the sender by email at info@orbit.com
When addressed to our clients, any opinions or advice contained in this document are subject to the terms and conditions expressed in the governing Orbit - client engagement letter. While the Orbit team tries its best to keep the information up-to-date in line with the evolving trends, Orbit assumes no responsibility for the validity and correctness of the information provided.
Orbit Lifesciences is on a mission to deliver quality health through its innovative, evolving and growing product portfolio. Launched in 2004, Orbit is a part of Orbit Group.
With a strong focus on innovation, speed of execution & extensive networking Today, orbit Lifescience is reckoned as one of the fastest growing, multi-faceted progressive professional organization in building and delivering mutually beneficial business propositions ranging from In-licensing, Out-licensing and Exports of Finished Formulations.
This is Orbit Proprietary Material.